---

Overview

Keynote Speaker

Dr. Peter Staats
Chief Medical Officer, National Spine & Pain Centers

Panelists and Presenters

Dr. Eric Van Gieson
Program Manager, DARPA Biological Technologies Office

Imran Eba
Partner, Action Potential Venture Capital

Dr. Marom Bikson
Cattell Professor, Biomedical Engineering | The City College of New York of the City University of New York

Entrepenuer Presenters

Attila Borbath
Co-founder and CEO, Synergia Medical

Jennifer Ernst
Co-founder and CEO, Tivic Health Systems Inc.

Ash Attia
CEO, Bionic Vision Technologies

Nicolas Vachicouras
CEO, Neurosoft Bioelectronics

Dr. Andrew Wilder
CEO, IRIS Biomedical

Anuj Bhardwaj
CEO, SecondWave Systems Inc.

Agenda

9:00-9:15

Introductions

9:15-9:30

Overview of the Bioelectronic Medicine Industry

James Cavuoto | Editor | Neurotech Reports

Presenting an overview of the bioelectronic medicine industry

9:30-9:45

Keynote Address

Peter Staats, M.D. | Chief Medical Officer | National Spine & Pain Centers

Speaking about the new directions in the industry.

9:45-10:15

Investment in Bioelectronic Medicine

Jennifer French | Senior Contributing Editor | Neurotech Reports | Moderator

Imran Eba | Partner | Action Potential Venture Capital

Brian Meshkin | Managing Partner | Profound Ventures

Tony Natale, M.D. | Managing Partner | Aperture Venture Partners

Investment professionals give their views on making investments in bioelectronic medicine.

10:15-10:30

Refreshments/Break

10:30-11:15

Entrepreneur Panel I

James Cavuoto | Editor | Neurotech Reports | Moderator

Attila Borbath | CEO | Synergia Medical

Nicolas Vachicouras, Ph.D. | CEO | Neurosoft Bioelectronics

Presentations from executives of new bioelectronic medicine firms.

11:15-12:00

Big Pharma and Neuromodulation

Jo Jo Platt | Contributing Editor | Neurotech Reports, Moderator

Chihiro Hosoya | Head of Venture Management & Business Development | Astellas Pharma

Arun Sridhar, Ph.D. | Entrepreneur & Former Head of Discovery at Galvani Bioelectronics

Glenn Cornett, M.D., Ph.D. | CSO | Kurve Therapeutics

Activity at firms such as GSK, Merck, and Astellas.

12:00-1:00

Luncheon

1:00-1:30

Luncheon Speaker

 Andrew Cornwell, Ph.D. | Director | Industrial and Strategic Collaborations | Cleveland FES Center

1:30-2:15

Innovations in the Industry

Victor Pikov, Ph.D. | Contributing Editor | Neurotech Reports | Moderator

Marom Bikson, Ph.D. | Professor of Biomedical Engineering | City College of New York

Hannah Claridge | The Technology Partnership plc

New tools for delivering therapy to visceral organs. Examining technologies like closed-loop stimulation, sub-threshold stimulation, focused ultrasound, and new waveforms.

2:15-3:00

Entrepreneur Panel II

James Cavuoto | Editor | Neurotech Reports | Moderator

Anuj Bhardwaj, Ph.D. | CEO | SecondWave Systems, Inc.

Manfred Franke, Ph.D. | CEO | Neuronoff Inc.

Presentations from executives of bioelectronic medicine startups.

3:00-3:15

Refreshments/Break

3:15-4:00

Entrepreneur Panel III

James Cavuoto | Editor | Neurotech Reports | Moderator

Jennifer Ernst | CEO & Co-founder | Tivic Health

Andrew Wilder, Ph.D. | CEO | IRIS Biomedical

More presentations from executives of emerging bioelectronic medicine firms.

4:00-4:45

The future of biolectronic medicine

Jeremy Koff | Senior Consulting Editor | Neurotech Reports | Moderator

Eric Hudak, Ph.D. | Program Director | NIH NINDS

Anthony Arnold | CEO | Precys

Examining where neuromodulation is likely to stand in the continuum of care alongside pharmaceuticals.

4:45-6:30

Cocktail Reception

 

 

 

Learn more